Reconnect

Deep Consciousness Technologies for Transformational Healthcare

Illustration

Targeted clinical problems are stress-related mood disorders (depression, anxiety, burnout, PTSD, addictions), which to date lack efficient pharmacotherapeutic solutions. Our pharmacological solution is a psychoactive process-catalyst drug, designed to support a novel transformation-based psychotherapy approach to efficiently treat the root cause of mood disorders.

 

 

Team

Team
  • Dr. Dr. Milan Scheidegger, Clinical research & therapy development
  • Dr. Dario Dornbierer, Pharmacology and drug development
  • Dr. Davor Kosanic, Social entrepreneurship
  •  

Contact

Logo